TRACEY PICK: Open Payments
NPI 1760444558 · SOUTH SIOUX CITY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$337 in 21 payments from 5 companies in 2025. Trend: 2023 $318 · 2024 $373 · 2025 $337
Food & beverage: $337
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $258 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: Ozempic, Wegovy, GVOKE HYPOPEN, Rybelsus, Kerendia, CAPLYTA.
Industry payments across NE — which companies pay providers there.
